Account
Case Studies

Development of an EU P&R strategy for an orphan drug incorporating payer insights

26/04/2023

Author:

Sarah Bailey
About the Author

Article Tags

HTA Orphan Drugs Pricing

Share this article

Related articles

Insider Insights
14.04.2025
Reflections on the March 2025 EU HTA Webinar 

On 21 March 2025, the European Commission hosted a public webinar to share updates on the implementa...

Read more
Insider Insights
09.04.2025
25 Years of NICE: Reflections and Achievements

Celebrating its 25th anniversary, NICE hosted a conference looking back at its progress and ahead to...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch